Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dffbd04747d5d9b9492e7f2ac61db6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-42 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-42 |
filingDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1395a8b6be0d6fe321e323ae2d435a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5aff32576769e372f78afc6792cc789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4482ae8c0303684f8defcc812a94e29b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76504cf13888252ee74919fe6dc3a55c |
publicationDate |
2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1875915-A1 |
titleOfInvention |
Therapeutic agent for chronic obstructive pulmonary disease |
abstract |
Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below:n nor a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R 1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R 2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y 1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R 3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y 2 represents a substituted or unsubstituted alkylene or an alkenylene; R 4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R 5 represents a hydrogen atom or a substituted or unsubstituted alkyl. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2272844-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2272844-A4 |
priorityDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |